Matches in Wikidata for { <http://www.wikidata.org/entity/Q61727929> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q61727929 description "assaig clínic" @default.
- Q61727929 description "clinical trial" @default.
- Q61727929 description "clinical trial" @default.
- Q61727929 description "clinical trial" @default.
- Q61727929 description "clinical trial" @default.
- Q61727929 description "ensaio clínico" @default.
- Q61727929 description "ensayo clínico" @default.
- Q61727929 description "ensayu clínicu" @default.
- Q61727929 description "essai clinique" @default.
- Q61727929 description "klinisch onderzoek" @default.
- Q61727929 description "клінічне випробування" @default.
- Q61727929 description "կլինիկական փորձարկում" @default.
- Q61727929 name "An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)" @default.
- Q61727929 name "An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)" @default.
- Q61727929 type Item @default.
- Q61727929 label "An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)" @default.
- Q61727929 label "An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)" @default.
- Q61727929 prefLabel "An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)" @default.
- Q61727929 prefLabel "An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)" @default.
- Q61727929 P1132 Q61727929-11E679FD-5C5B-4D26-B0BC-332FFD8ED264 @default.
- Q61727929 P1476 Q61727929-108C0958-E696-43E8-997E-D34AB487AF77 @default.
- Q61727929 P17 Q61727929-8717EA49-9AAA-4F22-8A32-C5D97C0B3407 @default.
- Q61727929 P1813 Q61727929-552A09B6-3653-4F07-9D35-832B8D3DCBE7 @default.
- Q61727929 P2899 Q61727929-B108FC6D-3322-4B1C-BDAF-832528CAE787 @default.
- Q61727929 P3098 Q61727929-CA754DE9-A916-47FF-88BA-BD84626615F2 @default.
- Q61727929 P31 Q61727929-1144649C-C006-432D-A814-3DF63E1DDF7B @default.
- Q61727929 P4844 Q61727929-6856B1A1-4E8C-45FC-8E25-AD702E579069 @default.
- Q61727929 P580 Q61727929-0992FE2D-D0DC-45A1-9F95-6B0B5086EE7B @default.
- Q61727929 P582 Q61727929-80DE83FB-885E-42BE-A2DA-DF0BFD7F81EB @default.
- Q61727929 P6099 Q61727929-2EBF18EE-4883-4B21-880B-8EA0BEB007C5 @default.
- Q61727929 P8363 Q61727929-2BAF1006-8C19-4C74-A3EF-FE36EAB7C0D6 @default.
- Q61727929 P1132 "+112" @default.
- Q61727929 P1476 "SQUINT (Squamous Immunotherapy Nivolumab-Ipilimumab Trial): An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)" @default.
- Q61727929 P17 Q38 @default.
- Q61727929 P1813 "SQUINT" @default.
- Q61727929 P2899 "+18" @default.
- Q61727929 P3098 "NCT03823625" @default.
- Q61727929 P31 Q30612 @default.
- Q61727929 P4844 Q7041828 @default.
- Q61727929 P580 "2017-09-13T00:00:00Z" @default.
- Q61727929 P582 "2021-02-28T00:00:00Z" @default.
- Q61727929 P6099 Q42824440 @default.
- Q61727929 P8363 Q78089383 @default.